These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34518350)

  • 1. [Not Available].
    Stainforth-Dubois M; McDonald EG
    CMAJ; 2021 Sep; 193(36):E1438-E1441. PubMed ID: 34518350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuropathy in too rapid HbA1c decrease].
    Sommer C
    MMW Fortschr Med; 2015 Jun; 157(11):34. PubMed ID: 26049343
    [No Abstract]   [Full Text] [Related]  

  • 3. The Human Factor: The Cost of Switching from Analog to Human Insulin.
    Tsai A
    Diabetes Forecast; 2017 Mar; 70(2):44-47. PubMed ID: 29897684
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensive insulin therapy in type 2 diabetes mellitus].
    Jermendy G
    Orv Hetil; 2012 Sep; 153(38):1487-93. PubMed ID: 22985663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin as an adjunctive therapy for NIDDM.
    Waterman PE
    Nurse Pract; 1996 Apr; 21(4):150-2. PubMed ID: 8801483
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of very tight blood glucose control in type 2 diabetes.
    Home P
    BMJ; 2008 Mar; 336(7642):458-9. PubMed ID: 18309965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of very tight glucose control in type 2 diabetes in question.
    Idris I
    Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839
    [No Abstract]   [Full Text] [Related]  

  • 10. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines].
    Adler AI; Shaw EJ; Stokes T; Ruiz F
    Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980
    [No Abstract]   [Full Text] [Related]  

  • 11. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 12. Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?
    Schernthaner G; Ritz E; Schernthaner GH
    Nephrol Dial Transplant; 2010 Jul; 25(7):2044-7. PubMed ID: 20388630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetics: how you take the right choice].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():46-51; quiz 52. PubMed ID: 22916425
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment-Induced Neuropathy of Diabetes (TIND) in Pediatrics: A Case Report and Review of the Literature.
    Chandler E; Brown M; Wintergerst K; Doll E
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31613321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

  • 19. Under-recognised paradox of neuropathy from rapid glycaemic control.
    Leow MK; Wyckoff J
    Postgrad Med J; 2005 Feb; 81(952):103-7. PubMed ID: 15701742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
    Haneda M; Morikawa A
    Nephrol Dial Transplant; 2009 Feb; 24(2):338-41. PubMed ID: 19015168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.